Top 3 Health Care Stocks That May Dip This Month
Top 3 Health Care Stocks That May Dip This Month
As of Nov. 25, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年11月25日，醫療保健行業的三隻股票可能會向將動量視爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一個動量指標，它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數高於70時，資產通常被視爲超買。
Here's the latest list of major overbought players in this sector.
以下是該行業主要超買參與者的最新名單。
Conmed Corp (NYSE:CNMD)
康邁德公司（紐約證券交易所代碼：CNMD）
- On Oct. 30, Conmed reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of 99 cents per share. "Our third quarter results were largely in line with our expectations, and we remain focused on getting fully back on offense," commented Curt R. Hartman, CONMED's Chair of the Board, President, and Chief Executive Officer. "I am particularly proud of how our teams responded to the disruption from hurricanes Helene and Milton, which temporarily impacted our employees and facilities in the Southeast as well as many of our customers." The company's stock gained around 21% over the past month and has a 52-week high of $117.27.
- RSI Value: 70.45
- CNMD Price Action: Shares of Conmed gained 4.5% to close at $74.91 on Friday.
- 10月30日，Conmed公佈的季度收益爲每股1.05美元，超過了分析師共識估計的每股99美分。CONMED董事會主席、總裁兼首席執行官柯特·哈特曼評論說：「我們第三季度的業績基本符合我們的預期，我們仍然專注於全面恢復進攻。」「我爲我們的團隊如何應對颶風海倫和米爾頓造成的干擾感到特別自豪，這場颶風暫時影響了我們在東南部的員工和設施以及我們的許多客戶。」該公司的股票在過去一個月中上漲了約21％，創下了52周高點117.27美元。
- RSI 值：70.45
- CNMD價格走勢：週五，康邁德股價上漲4.5％，收於74.91美元。
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)
馬德里加爾製藥公司（納斯達克股票代碼：MDGL）
- On Oct. 31, Madrigal Pharmaceuticals reported better-than-expected third-quarter financial results. Bill Sibold, Chief Executive Officer of Madrigal, stated, "Our U.S. launch of Rezdiffra is progressing exceptionally well driven by the outstanding execution of our team. Growing adoption by prescribers, broader payer coverage and an increasing number of patients on therapy each contributed to the strong performance. This early success highlights the critical need for effective treatments for moderate to advanced NASH/MASH, which is expected to become the leading cause of liver transplants in the U.S." The company's stock gained around 65% over the past month and has a 52-week high of $368.29.
- RSI Value: 74.01
- MDGL Price Action: Shares of Madrigal Pharmaceuticals gained 5.5% to close at $347.45 on Friday.
- 10月31日，Madrigal Pharmicals公佈的第三季度財務業績好於預期。Madrigal首席執行官比爾·西博爾德表示：「在我們團隊出色的執行力的推動下，我們在美國推出的Rezdiffra進展異常順利。處方者的採用率越來越高，付款人的覆蓋範圍更廣，接受治療的患者數量也越來越多，所有這些都促成了強勁的表現。這一早期成功凸顯了對中度至晚期 NASH/MASH 進行有效治療的迫切需求，預計這將成爲美國肝移植的主要原因。」該公司的股票在過去一個月中上漲了約65％，創下了52周高點368.29美元。
- RSI 值：74.01
- MDGL價格走勢：週五，Madrigal Pharmicals的股價上漲5.5％，收於347.45美元。
Butterfly Network Inc (NYSE:BFLY)
蝴蝶網絡公司（紐約證券交易所代碼：BFLY）
- On Nov. 1, Butterfly Network reported better-than-expected quarterly financial results and issued FY24 revenue guidance above estimates. The company's stock gained around 78% over the past month and has a 52-week high of $3.55.
- RSI Value: 72.56
- BFLY Price Action: Shares of Butterfly Network fell 1.4% to close at $3.24 on Friday.
- 11月1日，Butterfly Network公佈的季度財務業績好於預期，併發布了高於預期的24財年收入指導。該公司的股票在過去一個月中上漲了約78％，創下52周高點3.55美元。
- RSI 值：72.56
- BFLY價格走勢：週五，蝴蝶網絡股價下跌1.4％，收於3.24美元。
Read This Next:
接下來閱讀這篇文章：
- Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin
- 吉姆·克萊默說這隻股票是比特幣遊戲，他更喜歡擁有比特幣
譯文內容由第三人軟體翻譯。
